title: Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.
abstract: In 1999 and 2000 the Royal College of Physicians published guidelines for the prevention and treatment of osteoporosis [Royal College of Physicians. Osteoporosis: clinical guidelines for the prevention and treatment. London: Royal College of Physicians; 1999; Royal College of Physicians and Bone and Tooth Society of Great Britain. Update on pharmacological interventions and an algorithm for management. London, UK: Royal College of Physicians; 2000.; Royal College of Physicians. Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment; Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. London, UK: Royal College of Physicians; 2002]. Since then, there have been significant advances in the field of osteoporosis including the development of new techniques for measuring bone mineral density, improved methods of assessing fracture risk and new treatments that have been shown to significantly reduce the risk of fractures. Against this background, the National Osteoporosis Guideline Group (NOGG), in collaboration with many Societies in the UK, have updated the original guidelines [Royal College of Physicians, National Osteoporosis Guideline Group on behalf of the Bone Research Society, British Geriatrics Society, British Orthopaedic Association, British Society of Rheumatology, National Osteoporosis Society, Osteoporosis 2000, Osteoporosis Dorset, Primary Care Rheumatology Society, Society for Endocrinology. Osteoporosis. Clinical guideline for prevention and treatment, Executive Summary. University of Sheffield Press; 2008], a practical summary of which is detailed below. The management algorithms are underpinned by a health economic analysis applied to the epidemiology of fracture in the UK.
authors.affiliation: University of Cambridge School of Clinical Medicine, Department of Medicine, Cambridge, United Kingdom. jec1001@cam.ac.uk
authors.forename: J
authors.initials: J
authors.lastname: Compston
authors.forename: A
authors.initials: A
authors.lastname: Cooper
authors.forename: C
authors.initials: C
authors.lastname: Cooper
authors.forename: R
authors.initials: R
authors.lastname: Francis
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
authors.forename: D
authors.initials: D
authors.lastname: Marsh
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: D M
authors.initials: DM
authors.lastname: Reid
authors.forename: P
authors.initials: P
authors.lastname: Selby
authors.forename: M
authors.initials: M
authors.lastname: Wilkins
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis* / Q000628:therapy*; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D006113:United Kingdom